Oracle (NYSE:ORCL) Stock Price Down 2% Following Insider Selling

Oracle Corporation (NYSE:ORCL)’s share price dropped 2% during mid-day trading on Friday following insider selling activity. The stock traded as low as $144.40 and last traded at $147.60. Approximately 38,485,695 shares changed hands during trading, an increase of 31% from the average session volume of 29,372,295 shares. The stock had previously closed at $150.59.

Specifically, CEO Michael Sicilia sold 10,882 shares of the firm’s stock in a transaction dated Wednesday, September 16th. The stock was sold at an average price of $139.94, for a total value of $1,522,827.08. Following the completion of the transaction, the chief executive officer directly owned 149,084 shares in the company, valued at $20,862,814.96. This trade represents a 6.80% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Analyst Ratings Changes

A number of research firms recently issued reports on ORCL. BMO Capital Markets decreased their target price on shares of Oracle from $220.00 to $195.00 and set an “outperform” rating for the company in a research report on Friday, September 11th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $284.00 price objective on shares of Oracle in a report on Friday, September 11th. DA Davidson reaffirmed a “buy” rating and issued a $225.00 price target on shares of Oracle in a report on Friday, September 11th. Royal Bank Of Canada reduced their price objective on shares of Oracle from $190.00 to $165.00 and set a “sector perform” rating for the company in a research report on Friday, September 11th. Finally, Stifel Nicolaus reduced their target price on Oracle from $220.00 to $200.00 and set a “buy” rating for the company in a report on Friday, September 11th. Two equities research analysts have rated the stock with a Strong Buy rating, thirty have assigned a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $252.58.

Key Headlines Impacting Oracle

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: Oracle’s reported $664 billion cloud backlog and approximately $30 billion in AI-related deals continue to support expectations for substantial future revenue growth. Analysts also point to the company’s strong recent earnings and cloud momentum as evidence that demand remains robust. Oracle Shares Climb Despite Layoffs as $30 Billion AI Deals Fuel Growth
• Positive Sentiment: Oracle Health won a new customer in San Juan Regional Medical Center, which will use Oracle’s technology to improve patient flow, bed management and operational visibility. The contract reinforces the company’s broader cloud and healthcare software opportunity. San Juan Regional Medical Center Teams with Oracle Health
• Neutral Sentiment: Technical commentary remains mixed: ORCL recently moved above its 20-day moving average and is building potential support near its 50-day average, but it remains below its 200-day average. This suggests a possible short-term rebound without confirming a lasting recovery. XLK, Oracle and AMD Forecast
• Negative Sentiment: Investors are increasingly concerned that Oracle is borrowing heavily and generating deeply negative free cash flow to build AI data-center capacity. Higher interest rates, large leases and questions about when the backlog will convert into cash are weighing on the stock’s valuation. Oracle, CoreWeave Dump on AI Financing Risks
• Negative Sentiment: Fresh layoffs and disclosures that Oracle’s internal AI rollout took longer than expected are raising concerns about execution and employee disruption. A CEO share sale also adds a modest negative signal, although it occurred under a pre-arranged Rule 10b5-1 plan. Oracle Executive Discusses Delayed Internal AI Rollout

Oracle Stock Down 2.0%

The company has a market capitalization of $446.30 billion, a PE ratio of 23.13, a price-to-earnings-growth ratio of 1.02 and a beta of 1.74. The company has a quick ratio of 1.12, a current ratio of 1.17 and a debt-to-equity ratio of 1.89. The firm has a 50-day moving average of $141.25 and a two-hundred day moving average of $160.45.

Oracle (NYSE:ORCL) last issued its quarterly earnings data on Thursday, September 10th. The enterprise software provider reported $1.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.74 by $0.18. Oracle had a return on equity of 48.85% and a net margin of 26.36%.The firm had revenue of $19.34 billion during the quarter, compared to the consensus estimate of $19.13 billion. During the same period last year, the company earned $1.47 EPS. The company’s quarterly revenue was up 29.6% on a year-over-year basis. Oracle has set its Q2 2027 guidance at 1.850-1.930 EPS and its FY 2027 guidance at 8.100-8.100 EPS. Equities research analysts predict that Oracle Corporation will post 6.65 earnings per share for the current fiscal year.

Oracle Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 23rd. Stockholders of record on Friday, October 9th will be paid a $0.50 dividend. The ex-dividend date of this dividend is Friday, October 9th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.4%. Oracle’s payout ratio is presently 31.35%.

Hedge Funds Weigh In On Oracle

Institutional investors have recently bought and sold shares of the company. Basepoint Wealth LLC acquired a new position in shares of Oracle during the fourth quarter valued at approximately $26,000. Basso Capital Management L.P. acquired a new position in Oracle during the fourth quarter worth about $29,000. Maseco LLP bought a new stake in Oracle in the first quarter worth about $29,000. Persistent Asset Partners Ltd bought a new stake in shares of Oracle in the 2nd quarter worth approximately $29,000. Finally, Markowski Investments bought a new position in shares of Oracle in the second quarter valued at $32,000. 42.44% of the stock is owned by institutional investors and hedge funds.

Oracle Company Profile

Oracle Corporation is a global enterprise technology company that develops and provides database software, cloud infrastructure, business applications and related technology services. Its offerings help organizations manage data, run applications, support business operations and build technology environments across on-premises, hybrid and cloud-based settings.

The company’s products include Oracle Database, MySQL, Java, Oracle Cloud Infrastructure and a broad portfolio of cloud applications for enterprise resource planning, financial management, human resources, supply chain management, customer experience and industry-specific operations.